´À¸®°Ô ³ªÀ̵å´Â ±â¾ï·ÂÀÇ ºñ¹Ð
- ÀúÀÚ(±Û)±èÈñÁø
- ÃâÆÇ»ç¾Þ±ÛºÏ½º
- ¹ßÇàÀÏ2024³â 04¿ù 16ÀÏ
Ä¡¸ÅÀÇ ´Ù¾çÇÑ Æ¯¼º°ú Á¶±â Áø´Ü°ú Ä¡·á¿¡ Àû¿ëÇϱâ À§ÇÑ ¿©·¯ À¶ÇÕ ¿¬±¸µéÀ» ÁøÇàÇϰí ÀÖ½À´Ï´Ù.
ÇѾç´ëÇб³º´¿ø ½Å°æ°ú¿¡¼´Â Àü¹®ÈµÈ Ä¡·áÁø°ú ¿¬±¸ÁøµéÀÌ Á¤È®ÇÑ Ä£´Ü ¹× ÃÖ÷´Ü Ä¡·á¸¦ À§ÇØ ±âÃÊÀÇÇÐ, ¿µ»óÀÇÇÐ, ÇÙÀÇÇаú¿Í ¿¬°èÇÏ¿© ȯÀÚÀÇ ÀüÀÎÀûÀÎ Ä¡·á¸¦ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. 2008³âºÎÅÍ ÇöÀç ±îÁö ¼ºµ¿±¸ Ä¡¸ÅÁö¿ø¼¾Å͸¦ Á÷Á¢ ¿î¿µÀ» ÅëÇÑ Ä¡¸Å ȯÀÚ Áø´Ü ¹× °ü¸®ÀÇ ³ëÇϿ츦 ÃàÀûÇÏ¿´°í, 2018³âºÎÅÍ º¸°Çº¹ÁöºÎ »êÇÏ Ä¡¸Å±Øº¹°úÁ¦¿Í ¹Ì·¡ºÎ »êÇÏ ³ú¿øÃµ °úÁ¦¸¦ ¼öÇàÇÏ¿©, °³ÀÎÇü, ¸ÂÃãÇü Ä¡¸Å Ä¡·á ¹× ¿øÀαԸíÀ» ½ÃÀÛÇÏ¿´½À´Ï´Ù. 2023³âºÎÅÍ ¿¬±¸Àç´Ü°ú ÇÔ²² ÀÎÁöÀúÇÏ À§Ç豺ÀÇ Àû±ØÀû °ü¸®¸¦ ÅëÇØ Ä¡¸Å ¿¹¹æ¿¡ ¾ÕÀå¼°í ÀÖ½À´Ï´Ù. ÇѾç´ëÇб³º´¿ø ½Å°æ°úÀÇ Àû±ØÀûÀÎ Á¢±Ù°ú ¿¹¹æ, ºü¸¥ Ä¡·á°¡ ¿©·¯ºÐÀÇ ³ú°Ç°À» ÁöÄѵ帮°Ú½À´Ï´Ù.
| Á¦ ¸ñ | Amyloid Burden in Alzheimer's Disease Patients Is Associated with Alterations in Circadian Rhythm. | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2021 | ¹ßÇ¥Áö | Dementia Neurocog Dis. |
| Á¦ ¸ñ | Impact of an Education Program for Caregivers of Patients with Alzheimer¡¯s Disease on Treatment Discontinuation and Compliance in Korea. | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2021 | ¹ßÇ¥Áö | J Clin Neurol |
| Á¦ ¸ñ | Lecanemab: Appropriate Use Recommendations by Korean Dementia Association | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | Dementia Neurocog Dis. |
| Á¦ ¸ñ | Prediction of Amyloid ¥â-Positivity with both MRI Parameters and Cognitive Function Using Machine Learning | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2023 | ¹ßÇ¥Áö | The Korean Society of Radiology |
| Á¦ ¸ñ | Blood-brain barrier breakdown is linked to tau pathology and neuronal injury in a differential manner according to amyloid deposition | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2023 | ¹ßÇ¥Áö | Journal of Cerebral Blood Flow & Metabolism |
| Á¦ ¸ñ | A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer¡¯s Disease Already Receiving Donepezil (ROMEO-AD) | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2023 | ¹ßÇ¥Áö | Neurol Ther |
| Á¦ ¸ñ | Impact of the Ventricle Size on Alzheimer¡¯s Disease Progression: A Retrospective Longitudinal Study | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | Dementia Neurocog Dis. |
Ä¡¸Å·Î Àüȯ½ÃŰ´Â À§ÇèÀÎÀÚ È®Àΰú Á¶Àý
Ä¡¸ÅÀÇ ´Ù¾çÇÑ Æ¯¼ºÀ» ¹àÈ÷°í, ¹ÙÀÌ¿À ¸¶Ä¿ ¿¬±¸¸¦ ÅëÇØ Á¶±â Áø´Ü°ú Ä¡·á¿¡ Àû¿ëÇϱâ À§ÇÑ ¿©·¯ À¶ÇÕ ¿¬±¸µéÀ» ÁøÇàÇϰí ÀÖ½À´Ï´Ù. Ä¡¸Å·Î Áø´ÜµÈ ½ÃÁ¡ºÎÅÍ ½ÃÀ۵Ǵ ¡®È¯ÀڷμÀÇ ¿©Á¤(Journey)¡¯À» ÇÔ²² ÇÒ °¡À̵åÀÌÀÚ µ¿¹ÝÀڷμ ¾à¹° 1Â÷ Ä¡·á¿Í ÇÔ²² ÃßÀû °üÂû, ÀÌÈÄ °Ç°°ü¸®±îÁö Ä¡¸Å ȯÀÚº° ¸ÂÃãÇüÀ¸·Î Â÷º°ÈµÈ Áø·á ¼ºñ½º¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. Ä¡¸Å ȯÀÚÀÇ Çʿ並 ÃæÁ·½Ãų ¼ö ÀÖµµ·Ï ÃÖ´ëÇÑ ³ë·ÂÇϰڽÀ´Ï´Ù!
Ä¡¸Å´Â ¹Ýµå½Ã ¿¹¹æÇÏ°í °íÄ¥¼ö ÀÖ½À´Ï´Ù. ³ú°Ç°À» À§ÇÏ¿© ¿½ÉÈ÷ ³ë·ÂÇսôÙ.

ÇѾç´ëÇб³º´¿øÀº 1972³â °³¿ø ÀÌÈÄ, »ç¶ûÀÇ ½Çõ Á¤½ÅÀ» ¹ÙÅÁÀ¸·Î ÀÇ·áÀÇ ÇѰ迡 µµÀüÇϸç, Çõ½ÅÀûÀÎ ¼º°ú¸¦ ÀÌ·ï¿Ô½À´Ï´Ù. ·ù¸¶Æ¼½º ¹× ½Å°æ°èÁúȯ Ä¡·áÀÇ ¼±µµ º´¿ø°ú ÁßÁõ ¾ÏÁúȯ µî¿¡ ÃֽеðÁöÅÐ Çõ½Å ±â¼ú°ú ¿¬±¸Á߽ɺ´¿øÀ¸·Î¼ AI, ºòµ¥ÀÌÅÍ µîÀ» Ȱ¿ëÇÑ ÀÓ»ó ¿¬±¸¸¦ °ÈÇÏ¸ç ¹Ì·¡ ÀÇÇÐÀ» À̲ø°í ÀÖ½À´Ï´Ù.
¼¿ïƯº°½Ã ¼ºµ¿±¸ ¿Õ½Ê¸®·Î 222-1